---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-091280"
form_type: "8-K"
ticker: "TWST"
cik: "0001581280"
company_name: "Twist Bioscience Corp"
filed_at: "2026-08-05T21:27:14+00:00"
generated_at: "2026-08-05T21:28:10.763933+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Twist Bioscience prices upsized $300M public offering of common stock at $96/share

## Summary
- Offering of 3,125,000 shares at $96.00 per share; underwriters' option for 468,750 additional shares exercised in full.
- Net proceeds expected to be approximately $327.1 million after underwriting discounts and expenses.
- Offering upsized from originally proposed $250 million to $300 million; expected to close August 6, 2026.
- Proceeds to fund R&D, manufacturing capacity expansion, product offerings, and working capital.
- Joint book-running managers: Goldman Sachs, William Blair, Leerink Partners, Guggenheim Securities.

## SEC filing metadata
- accession: 0001104659-26-091280
- form_type: 8-K
- ticker: TWST
- cik: 0001581280
- company_name: Twist Bioscience Corp
- filed_at: 2026-08-05T21:27:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1581280/000110465926091280/0001104659-26-091280-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1581280/000110465926091280/tm2622018d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-091280
- JSON: https://secwatch.observer/filing/0001104659-26-091280.json
- Plain text: https://secwatch.observer/filing/0001104659-26-091280.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.